Flemming Ørnskov
Photo: Antoine Reyre, CC BY-SA 4.0, via Wikimedia Commons12

Flemming Ørnskov

Danish pharmaceutical executive (born 1958)

Flemming Ørnskov (born 24 January 1958) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma since October 2019.2

From Wikipedia’s article on Flemming Ørnskov (this version), CC BY-SA 4.0.

Born Jan 24, 1958.1

About

He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel. He previously worked for Bayer, Bausch & Lomb and Novartis.

He is also the non-executive chairman of Waters Corporation, a position he's been holding since 2017.

Ørnskov was educated at the Esbjerg Gymnasium. He received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University. Ørnskov is qualified as a doctor in Denmark and has experience as a practicing hospital physician.

Ørnskov led Galderma's IPO on the Zurich stock exchange on March 22, 2024, one of the biggest offerings in Europe in years and the biggest in Switzerland since 2017. He declares Galderma plans to use the proceeds to pay down debt and invest in its pipeline.

From Wikipedia’s article on Flemming Ørnskov, shared under CC BY-SA 4.0.2

Companies

Early life and education

  • Date not recordedHarvard T.H. Chan School of Public Health master's degree; public health3 4
  • Date not recordedUniversity of Copenhagen Doctor of Medicine3 4
  • Date not recordedINSEAD Master of Business Administration3

Career

Occupation: business executive.7

Personal life

  • BornJan 24, 1958, Esbjerg4 8
  • CitizenshipKingdom of Denmark9